Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
45.85    0.05 (0.11%)
Bid:
45.60
Ask:
45.90
Spread: 0.30 (0.658%)
Market Cap: £290.17m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

2 Jul 2010 10:50

RNS Number : 7282O
Marston's PLC
02 July 2010
 



Notification of interests of directors

 2 July 2010

 

The Company announces that on 1 July 2010 the Directors listed below were granted awards over ordinary shares in the Company under the Company's 2004 Long Term Incentive Plan with HM Revenue & Customs (HMRC) Approved Schedule (the "Plan"). Previously, nil cost options have been granted under the 2004 Long Term Incentive Plan ("LTIP Awards").

Awards under the Plan are structured as Approved Performance Share Plan Awards ("APSP Awards") and comprise three elements: (i) an HMRC Approved Option over shares with a total value at the date of grant of £30,000 with an exercise price of 94.6 pence per share; (ii) a "Linked Award" which is a funding award in the form of a nil cost option (i.e. in the form of an LTIP Award) over such number of shares whose total value at exercise equals £30,000; and (iii) an LTIP Award in the form of a nil cost option over shares to the value of the remainder of the APSP Award above the £30,000 limit. 

Subject to the satisfaction of the performance conditions which are based on EPS growth; the APSP Awards will vest and become exercisable in three years.

In addition to satisfaction of these performance conditions, the Approved Option will only become exercisable in the event that the market value of a share at exercise is greater than 94.6 pence per share. If the Linked Award is then used to fund the exercise price of the Approved Option, it will be satisfied by shares from the Company's employee benefit trust. Following the exercise of the Linked Award, these shares will be retained by the trust and not delivered to the participant.

In the event that the market value at exercise is less than 94.6 pence per share, the Approved Option will lapse and the maximum number of shares subject to the Linked Award will become available to the participant to exercise as an unapproved LTIP option.

Director

Number of shares subject to APSP Award (Approved Option and LTIP Award)

Maximum number of shares subject to Linked Award

Ralph Findlay

459,534

31,712

Derek Andrew

275,600

31,712

Stephen Oliver

275,000

31,712

Andrew Andrea

253,699

31,712

Alistair Darby

275,000

31,712

 

The notification of these transactions is made pursuant to DTR 3.1.4R (1)(a) and is also deemed to be disclosure made in accordance with Section 793 of the Companies Act 2006 where appropriate.

Enquiries: Anne-Marie Brennan, Company Secretary, Marston's PLC, +44 (0) 1902 329163

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEANXAELNEEEF
Date   Source Headline
1st Jun 20262:38 pmRNSTotal Voting Rights
19th May 202611:12 amRNSDirector Declaration
12th May 20267:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 28 MARCH 2026
1st Apr 20263:12 pmRNSTotal Voting Rights
2nd Mar 202611:43 amRNSTotal Voting Rights
23rd Feb 20265:33 pmRNSHolding(s) in Company
11th Feb 202611:21 amRNSDirector/PDMR Shareholding
2nd Feb 20263:28 pmRNSTotal Voting Rights
28th Jan 202612:37 pmRNSResult of AGM
28th Jan 20267:00 amRNSTrading update for the 17 weeks to 24 January 2026
12th Jan 20262:00 pmRNSBlock listing Interim Review
9th Jan 20269:30 amRNSPurchase of shares into the EBT
2nd Jan 20262:55 pmRNSTotal Voting Rights
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:46 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
29th Dec 202510:44 amRNSDirector/PDMR Shareholding
12th Dec 202511:07 amRNSAnnual Financial Report
11th Dec 20259:54 amRNSPurchase of shares into the EBT
1st Dec 20254:15 pmRNSTotal Voting Rights
28th Nov 202512:36 pmRNSDirector/PDMR Shareholding
28th Nov 202512:30 pmRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSPRELIMINARY RESULTS
28th Oct 20254:54 pmRNSHolding(s) in Company
8th Oct 20257:00 amRNSTrading Update for 52 weeks to 27 September 2025
1st Oct 20254:16 pmRNSTotal Voting Rights
1st Sep 20253:22 pmRNSTotal Voting Rights
1st Aug 20254:17 pmRNSTotal Voting Rights
22nd Jul 20257:00 amRNSTrading Update for the 41 weeks to 12 July 2025
9th Jul 20252:35 pmRNSBlock listing Interim Review
1st Jul 20255:03 pmRNSTotal Voting Rights
26th Jun 20257:05 amRNSAppointment of Chief Financial Officer
13th May 20257:00 amRNSRESULTS FOR THE 26 WEEKS ENDED 29 MARCH 2025
1st May 20253:04 pmRNSTotal Voting Rights
1st Apr 20251:40 pmRNSTotal Voting Rights
20th Mar 202512:48 pmRNSPurchase of shares into the EBT
17th Mar 20251:10 pmRNSPurchase of shares into the EBT
4th Mar 20257:00 amRNSDirectorate Change
25th Feb 20259:24 amRNSHolding(s) in Company
21st Jan 20253:21 pmRNSResult of AGM
21st Jan 20257:00 amRNSTrading Update for the 16 weeks to 18 January 2025
13th Jan 20253:36 pmRNSPurchase of shares into the EBT
10th Jan 202510:13 amRNSBlock listing Interim Review
8th Jan 202511:55 amRNSHolding(s) in Company
2nd Jan 202511:27 amRNSTotal Voting Rights
23rd Dec 202412:15 pmRNSDirector/PDMR Shareholding
20th Dec 202410:47 amRNSPurchase of shares into the EBT
17th Dec 20244:22 pmRNSAnnual Financial Report
12th Dec 20242:59 pmRNSDirector/PDMR Shareholding
6th Dec 20249:51 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.